Los puntos clave no están disponibles para este artículo en este momento.
Abstract 6-Nitrodopamine (6-ND) is released from rat isolated atria and has positive chronotropic action, which is selectively blocked by β 1 -adrenoceptor antagonists at concentrations that do not affect the positive chronotropic effect induced by dopamine, noradrenaline, and adrenaline. Here the effects of (±)-propranolol, (±)-4-NO 2 -propranolol, and (±)-7-NO 2 -propranolol, were investigated in the rat isolated right atrium. The atrium was mounted in gassed (95%O 2 :5%CO 2 ), heated (37°C) glass chambers, containing Krebs-Henseleit’s solution. Tissues were allowed to equilibrate under a resting tension of 10mN for 1 hour, and the isometric tension was registered using a PowerLab system. (±)-propranolol, (±)-4-NO 2 -propranolol and (±)-7-NO 2 -propranolol, caused concentration-dependent falls in the spontaneous atrial frequency (pEC 50 were 4.80 ± 0.10, 4.64 ± 0.10, and 4.95 ± 0.10, respectively). Noradrenaline (1nM–30µM), and adrenaline (1nM–100µM), caused concentration-dependent increases in atrial rate. The calculated pA 2 values for (±)-propranolol, (±)-4-NO 2 -propranolol, and (±)-7-NO 2 -propranol obtained for noradrenaline-induced positive chronotropic effects were 8.21 ± 0.35, 6.41 ± 0.21, and 8.35 ± 0.35, respectively. The positive chronotropic effect induced by 6-ND (10pM) was blocked by (±)-propranolol (1µM), and (±)-4-NO 2 -propranolol (30nM). (±)-7-NO 2 -propranol (1µM) had no effect on 6-ND (10pM)-induced increases in atrial rate. The pEC 50 of (±)-propranolol, (±)-4-NO 2 -propranolol and (±)-7-NO 2 -propranolol were significantly shifted to the right in L-NAME treated atria. The discrepancy between pA 2 values of (±)-propranolol and its respective pEC 50 indicates that the falls in atrial rate induced by (±)-propranolol should not be attributed to b-adrenergic antagonism. The finding that (±)-4-NO 2 -propranolol causes falls in spontaneous atrial rate only in concentrations that affect 6-ND positive chronotropic effect, confirms the role of this catecholamine as endogenous modulator of heart chronotropism.
Oliveira et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: